铁离子遗传学：正确的“明星”是什么？ - Suppr

Suppr

超能文献

Irinogenetics: what is the right star?

作者信息

Innocenti Federico, Vokes Everett E, Ratain Mark J

出版信息

J Clin Oncol. 2006 May 20;24(15):2221-4. doi: 10.1200/JCO.2005.05.2464. Epub 2006 Apr 24.

DOI:10.1200/JCO.2005.05.2464

PMID:16636339

Abstract

摘要

相似文献

Irinogenetics: what is the right star?铁离子遗传学：正确的“明星”是什么？

J Clin Oncol. 2006 May 20;24(15):2221-4. doi: 10.1200/JCO.2005.05.2464. Epub 2006 Apr 24.

Insights, challenges, and future directions in irinogenetics.伊立替康遗传学的见解、挑战及未来方向

Ther Drug Monit. 2007 Jun;29(3):265-70. doi: 10.1097/FTD.0b013e318068623b.

Polymorphisms of the UDP-glucuronosyl transferase 1A genes are associated with adverse events in cancer patients receiving irinotecan-based chemotherapy.UGT1A 基因的多态性与接受伊立替康为基础化疗的癌症患者的不良事件相关。

Tohoku J Exp Med. 2013 Feb;229(2):107-14. doi: 10.1620/tjem.229.107.

Pharmacogenetics of uridine diphosphoglucuronosyltransferase (UGT) 1A family members and its role in patient response to irinotecan.尿苷二磷酸葡萄糖醛酸基转移酶（UGT）1A家族成员的药物遗传学及其在患者对伊立替康反应中的作用。

Drug Metab Rev. 2006;38(3):393-409. doi: 10.1080/03602530600739835.

Indispensability of UGT1A1*6 genotyping in Japanese cancer patients treated with irinotecan.UGT1A1*6基因分型在接受伊立替康治疗的日本癌症患者中的必要性。

Int J Clin Oncol. 2010 Apr;15(2):224-5. doi: 10.1007/s10147-010-0024-2. Epub 2010 Feb 24.

Comprehensive analysis of UGT1A polymorphisms predictive for pharmacokinetics and treatment outcome in patients with non-small-cell lung cancer treated with irinotecan and cisplatin.对接受伊立替康和顺铂治疗的非小细胞肺癌患者中预测药代动力学和治疗结果的UGT1A基因多态性的综合分析。

J Clin Oncol. 2006 May 20;24(15):2237-44. doi: 10.1200/JCO.2005.03.0239. Epub 2006 Apr 24.

NF-kappa B activation in topoisomerase I inhibitor-induced apoptotic cell death in human non-small cell lung cancer.拓扑异构酶I抑制剂诱导人非小细胞肺癌细胞凋亡过程中核因子-κB的激活

Ann N Y Acad Sci. 2000;922:343-4. doi: 10.1111/j.1749-6632.2000.tb07060.x.

Genetic testing for UGT1A1*28 and *6 in Japanese patients who receive irinotecan chemotherapy.对接受伊立替康化疗的日本患者进行UGT1A1*28和*6基因检测。

Ann Oncol. 2008 Dec;19(12):2089-90. doi: 10.1093/annonc/mdn645. Epub 2008 Oct 26.

Pharmacogenetics of irinotecan: a promoter polymorphism of UGT1A1 gene and severe adverse reactions to irinotecan.伊立替康的药物遗传学：UGT1A1基因启动子多态性与伊立替康严重不良反应

Invest New Drugs. 2005 Dec;23(6):539-45. doi: 10.1007/s10637-005-4022-6.

Severe irinotecan-induced toxicities in a patient with uridine diphosphate glucuronosyltransferase 1A1 polymorphism.一名具有尿苷二磷酸葡萄糖醛酸转移酶1A1基因多态性的患者出现严重的伊立替康诱导的毒性反应。

Clin Colorectal Cancer. 2005 May;5(1):61-4. doi: 10.3816/ccc.2005.n.018.

引用本文的文献

The role of UGT1A1 polymorphism in the management of colorectal cancer.UGT1A1基因多态性在结直肠癌治疗中的作用。

Oncol Rev. 2025 May 13;19:1547904. doi: 10.3389/or.2025.1547904. eCollection 2025.

All You Need to Know About Genetic Testing for Patients Treated With Irinotecan: A Practitioner-Friendly Guide.关于接受伊立替康治疗的患者的基因检测：一份通俗易懂的实用指南。

JCO Oncol Pract. 2022 Apr;18(4):270-277. doi: 10.1200/OP.21.00624. Epub 2021 Dec 3.

All You Need to Know About Genetic Testing for Patients Treated With Fluorouracil and Capecitabine: A Practitioner-Friendly Guide.氟尿嘧啶和卡培他滨治疗患者的遗传检测：实用指南

JCO Oncol Pract. 2020 Dec;16(12):793-798. doi: 10.1200/OP.20.00553. Epub 2020 Nov 16.

Multicenter, Randomized, Phase III Trial of Neoadjuvant Chemoradiation With Capecitabine and Irinotecan Guided by Status in Patients With Locally Advanced Rectal Cancer.多中心、随机、III 期临床试验：卡培他滨和伊立替康新辅助放化疗，指导局部进展期直肠癌患者的状态。

J Clin Oncol. 2020 Dec 20;38(36):4231-4239. doi: 10.1200/JCO.20.01932. Epub 2020 Oct 29.

Association between the UGT1A1*28 allele and hyperbilirubinemia in HIV-positive patients receiving atazanavir: a meta-analysis.UGT1A1*28 等位基因与接受阿扎那韦治疗的 HIV 阳性患者高胆红素血症的相关性：一项荟萃分析。

Biosci Rep. 2019 May 2;39(5). doi: 10.1042/BSR20182105. Print 2019 May 31.

and genotyping to predict adverse events during first-line FOLFIRI or FOLFOXIRI plus bevacizumab in metastatic colorectal cancer.以及基因分型，以预测转移性结直肠癌患者在一线FOLFIRI或FOLFOXIRI联合贝伐单抗治疗期间的不良事件。

Oncotarget. 2017 Dec 21;9(8):7859-7866. doi: 10.18632/oncotarget.23559. eCollection 2018 Jan 30.

A GWAS Study on Liver Function Test Using eMERGE Network Participants.一项使用eMERGE网络参与者进行的肝功能测试全基因组关联研究。

PLoS One. 2015 Sep 28;10(9):e0138677. doi: 10.1371/journal.pone.0138677. eCollection 2015.

UGT1A1*6, 1A7*3, and 1A9*22 genotypes predict severe neutropenia in FOLFIRI-treated metastatic colorectal cancer in two prospective studies in Japan.UGT1A1*6、1A7*3 和 1A9*22 基因型可预测日本两项前瞻性研究中接受 FOLFIRI 治疗的转移性结直肠癌患者的严重中性粒细胞减少症。

Cancer Sci. 2013 Dec;104(12):1662-9. doi: 10.1111/cas.12283. Epub 2013 Oct 27.

Polymorphisms of UGT1A1*6, UGT1A1*27 & UGT1A1*28 in three major ethnic groups from Malaysia.马来西亚三个主要族群中的 UGT1A1*6、UGT1A1*27 和 UGT1A1*28 多态性。

Indian J Med Res. 2012 Aug;136(2):249-59.

Uridine 5'-diphospho-glucuronosyltransferase genetic polymorphisms and response to cancer chemotherapy.尿苷二磷酸葡萄糖醛酸基转移酶遗传多态性与癌症化疗反应。

Future Oncol. 2010 Apr;6(4):563-85. doi: 10.2217/fon.10.17.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验